BioMarin Pharmaceutical Ownership | Who Owns BioMarin Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

BioMarin Pharmaceutical Ownership Summary


BioMarin Pharmaceutical is owned by 0.16% institutional investors, 0.82% insiders, and 99.02% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.35% of BMRN shares. Dodge & Cox Stock I is the top mutual fund, with 5.09% of its assets in BioMarin Pharmaceutical shares.

BMRN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioMarin Pharmaceutical0.16%0.82%99.02%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de23.51M12.35%$1.55B
Blackrock22.74M12.04%$1.87B
Vanguard group19.37M10.17%$1.27B
Primecap management co/ca/18.19M9.55%$1.20B
Dodge & cox14.75M7.74%$969.27M
Capital research global investors12.99M6.82%$853.94M
Viking global investors lp10.51M5.52%$690.86M
State street9.11M4.79%$598.94M
Ameriprise financial4.50M2.36%$295.80M
Norges bank3.57M1.87%$234.64M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp991.21K13.34%$70.07M
Boone capital management327.28K7.87%$23.14M
Eagle health investments lp419.21K6.75%$27.55M
Soleus capital management1.08M5.49%$76.30M
Sector gamma as217.35K4.91%$14.29M
Clearline capital lp377.48K3.28%$24.81M
Sio capital management141.13K2.97%$9.98M
Novo490.00K2.63%$34.64M
Viking global investors lp10.51M2.24%$690.86M
Rhenman & partners asset management ab250.62K1.69%$16.47M

Top Buyers

HolderShares% AssetsChange
Blackrock22.74M0.04%8.26M
Norges bank3.57M0.03%3.57M
Capital research global investors12.99M0.18%2.50M
Blackrock funding, inc. /de23.51M0.03%889.61K
Dodge & cox14.75M0.56%847.92K

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---1.46M
Jpmorgan chase1.55M0.01%-1.27M
1832 asset management---1.16M
Parnassus investments---873.00K
Vestal point capital, lp---860.00K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.57M0.03%3.57M$234.64M
Boone capital management327.28K7.87%327.28K$23.14M
Susquehanna fundamental investments169.48K0.16%169.48K$11.14M
Cubist systematic strategies165.41K0.07%165.41K$11.69M
Sio capital management141.13K2.97%141.13K$9.98M

Sold Out

HolderChange
Bryn mawr trust-2.00
Householder group estate & retirement specialist-3.00
Abich financial wealth management-5.00
Financial gravity asset management-7.00
Sanctuary wealth management-9.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202511-98.11%305,544-99.83%-0.00%7-97.61%1-99.45%
Dec 31, 2024565-5.04%182,776,8923.30%951.11%2852.15%178-10.55%
Sep 30, 2024591-0.17%176,679,197-4.12%920.97%279-3.13%1957.14%
Jun 30, 2024583-2.35%184,215,3300.81%971.04%28513.55%178-13.17%
Mar 31, 20245973.29%182,743,407-1.16%961.00%251-4.56%2053.02%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dodge & Cox Stock I9.77M5.09%-
Capital Group Growth Fnd of Amer Comp8.28M4.32%741.56K
American Funds Growth Fund of Amer A8.28M4.32%741.56K
Vanguard PRIMECAP Inv7.09M3.70%-75.32K
iShares Core S&P Mid-Cap ETF6.19M3.23%4.06K
Vanguard Total Stock Mkt Idx Inv6.13M3.20%97.13K
Vanguard US Total Market Shares ETF6.04M3.15%4.43K
Vanguard Capital Opportunity Inv5.50M2.87%-7.52K
Vanguard Small Cap Index4.79M2.50%27.91K
American Funds AMCAP A4.49M2.36%-115.70K

Recent Insider Transactions


DateNameRoleActivityValue
May 20, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$105.93K
May 02, 2025Hubbard Cristin EVP, Chief Commercial OfficerSell$17.72K
Mar 19, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$92.62K
Mar 06, 2025Guyer Charles Greg EVP, Chief Technical OfficerSell$501.36K
Feb 24, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$91.90K

Insider Transactions Trends


DateBuySell
2025 Q2-2
2025 Q1-3
2024 Q4-1
2024 Q3-1
2024 Q2-10

BMRN Ownership FAQ


Who Owns BioMarin Pharmaceutical?

BioMarin Pharmaceutical shareholders are primarily institutional investors at 0.16%, followed by 0.82% insiders and 99.02% retail investors. The average institutional ownership in BioMarin Pharmaceutical's industry, Biotech Stocks , is 63.96%, which BioMarin Pharmaceutical falls below.

Who owns the most shares of BioMarin Pharmaceutical?

BioMarin Pharmaceutical’s largest shareholders are Blackrock funding, inc. /de (23.51M shares, 12.35%), Blackrock (22.74M shares, 12.04%), and Vanguard group (19.37M shares, 10.17%). Together, they hold 34.56% of BioMarin Pharmaceutical’s total shares outstanding.

Does Blackrock own BioMarin Pharmaceutical?

Yes, BlackRock owns 12.04% of BioMarin Pharmaceutical, totaling 22.74M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.87B$. In the last quarter, BlackRock increased its holdings by 8.26M shares, a 57.05% change.

Who is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 13.34% of its assets in 991.21K BioMarin Pharmaceutical shares, valued at 70.07M$.

Who is the top mutual fund holder of BioMarin Pharmaceutical shares?

Dodge & Cox Stock I is the top mutual fund holder of BioMarin Pharmaceutical shares, with 5.09% of its total shares outstanding invested in 9.77M BioMarin Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools